Viyash Scientific Limited has informed the Exchange about Report On Distribution Of Sale Proceeds Of Fractional Shares
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Viyash Scientific Limited has submitted reports from its Audit Committee and Independent Directors certifying the distribution of sale proceeds from fractional shares to eligible shareholders under its composite scheme of amalgamation. The scheme, approved by NCLT on November 18, 2025 and effective from December 16, 2025, involved the amalgamation of Viyash Life Sciences and several other group entities into Viyash Scientific, with a share exchange ratio of 56 equity shares of INR 2 each for every 100 shares of INR 10 held in the amalgamating companies. The company allotted approximately 18.19 crore equity shares, including 13 fractional shares which were consolidated and sold in the open market on February 27, 2026. Net proceeds were distributed to 25 eligible shareholders on March 6 and March 9, 2026, at an average net price of INR 214.12 per share, yielding a net amount of INR 2,769.64 after deductions.
This is a routine regulatory compliance filing closing out the fractional share settlement process from the amalgamation scheme. It has no material impact on the stock price but confirms orderly execution of the merger and that small shareholders with fractional entitlements have been compensated as required.